We are live on ! Find out more
ASA

Armstrong Shaw Associates Portfolio holdings

AUM $95.2M
1-Year Est. Return 23.67%
This Fund
S&P 500
This Quarter Est. Return
+5.23%
1 Year Est. Return
+23.67%
3 Year Est. Return
+51.2%
5 Year Est. Return
+82.8%
10 Year Est. Return
+225.63%
AUM
$553M
AUM Growth
-$261M
Cap. Flow
-$290M
Cap. Flow %
-52.4%
Top 10 Hldgs %
37.82%
Holding
44
New
1
Increased
1
Reduced
36
Closed
2

Top Buys

Rank Stock Value
1
NOV icon
NOV
NOV
+$5.51M
2
DD icon
DuPont de Nemours
DD
+$184K

Sector Composition

Rank Sector Weight
1 Financials 23.54%
2 Healthcare 19.29%
3 Technology 14.63%
4 Consumer Discretionary 11.03%
5 Energy 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVS icon
1
CVS Health
CVS
$137B
$23.6M 4.26%
312,951
-161,270
-34% -$12.2M
CMCSK
2
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
$23.5M 4.25%
440,427
-238,037
-35% -$12.7M
ST icon
3
Sensata Technologies
ST
$6.65B
$21.3M 3.84%
454,586
-246,980
-35% -$10.8M
F icon
4
Ford
F
$57.3B
$21.1M 3.82%
1,225,360
-667,999
-35% -$10.9M
HAL icon
5
Halliburton
HAL
$27.9B
$20.7M 3.75%
291,894
-160,712
-36% -$10.3M
COF icon
6
Capital One
COF
$124B
$20.4M 3.69%
247,447
-134,872
-35% -$10.5M
DD icon
7
DuPont de Nemours
DD
$18.6B
$20M 3.62%
153,680
+1,440
+0.9% +$184K
TYC
8
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
$19.8M 3.58%
414,958
-168,070
-29% -$7.57M
AIG icon
9
American International
AIG
$41.9B
$19.6M 3.54%
359,007
-178,188
-33% -$9.43M
JPM icon
10
JPMorgan Chase
JPM
$939B
$19.2M 3.47%
333,128
-183,219
-35% -$10.3M
WFC icon
11
Wells Fargo
WFC
$261B
$18.5M 3.34%
351,205
-187,336
-35% -$9.42M
CPN
12
DELISTED
Calpine Corporation
CPN
$18.2M 3.28%
762,577
-413,960
-35% -$9.39M
OPLN
13
Openlane
OPLN
$4.17B
$17.5M 3.17%
1,452,823
-297,515
-17% -$3.44M
MET icon
14
MetLife
MET
$61B
$17.4M 3.15%
351,737
-274,679
-44% -$12.9M
TNL icon
15
Travel + Leisure Co
TNL
$4.54B
$16.2M 2.93%
474,787
-279,808
-37% -$9.19M
CB icon
16
Chubb
CB
$140B
$16M 2.9%
154,657
-84,429
-35% -$8.64M
ELV icon
17
Elevance Health
ELV
$81.9B
$15.9M 2.88%
147,887
-2,558
-2% -$264K
HON icon
18
Honeywell
HON
$77.1B
$15.4M 2.78%
184,035
-90,627
-33% -$7.58M
GS icon
19
Goldman Sachs
GS
$313B
$15.1M 2.72%
89,971
-48,873
-35% -$7.89M
MSFT icon
20
Microsoft
MSFT
$2.84T
$14.5M 2.63%
348,412
-189,895
-35% -$7.69M
TMO icon
21
Thermo Fisher Scientific
TMO
$211B
$13.7M 2.48%
116,083
-61,094
-34% -$7.19M
WFT
22
DELISTED
Weatherford International plc
WFT
$13.6M 2.46%
591,700
-505,362
-46% -$10.4M
EMC
23
DELISTED
EMC CORPORATION
EMC
$12.9M 2.33%
490,446
-271,418
-36% -$7.17M
HOUS
24
DELISTED
Anywhere Real Estate
HOUS
$12.9M 2.33%
342,387
-183,891
-35% -$7.14M
RTX icon
25
RTX Corp
RTX
$287B
$12M 2.16%
164,700
-89,570
-35% -$6.6M

Similar funds

Armstrong Shaw Associates's Q2 2014 Portfolio in Review

As of Q2 2014, Armstrong Shaw Associates held 44 positions worth $553M, down 32% from $814M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Armstrong Shaw Associates withdrew a net $290M in Q2 2014, closing 2 positions and reducing 36 holdings. Its most notable exit was ADT Corp, an estimated $11.1M position sold in full.

By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 24% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Armstrong Shaw Associates opened a new position in NOV worth $6.09M.

  • Armstrong Shaw Associates's largest Q2 2014 buy was NOV: 73,966 shares worth $6.09M.
  • Armstrong Shaw Associates added most to DuPont de Nemours in Q2 2014, an estimated $184K increase.
  • Armstrong Shaw Associates's biggest Q2 2014 reduction was COVIDIEN PLC COM SHS NEW (IRELAND), cutting an estimated $16.4M.
  • Armstrong Shaw Associates fully exited ADT Corp in Q2 2014, selling an estimated $11.1M.
  • Armstrong Shaw Associates's ten largest holdings make up 38% of its $553M portfolio in Q2 2014.
  • Armstrong Shaw Associates opened 1 new position and closed 2 in Q2 2014.
  • Armstrong Shaw Associates's portfolio value fell 32% quarter-over-quarter to $553M.

Based on Armstrong Shaw Associates's 13F filing for Q2 2014, filed 18 Jul 2014.